Evidence map›Paper›PMID 38411555›Full record

ArticleJournal of the American Chemical Society2024

Development of Oxadiazolone Activity-Based Probes Targeting FphE for Specific Detection of

Jeyun Jo, Tulsi Upadhyay, Emily C Woods, Ki Wan Park, Nichole J Pedowitz, Joanna Jaworek-Korjakowska, Sijie Wang, Tulio A Valdez, Matthias Fellner, Matthew Bogyo

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Unique structural and ligand-binding properties of theProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Imaging ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Unique structural and ligand binding properties of thebioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. An mRNA Display Approach for Covalent Targeting of aJournal of the American Chemical Society · 2025
    Article
  9. An mRNA Display Approach for Covalent Targeting of abioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Jeyun JoDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305, United States.ORCID 0000-0002-6701-0452
Tulsi UpadhyayDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305, United States.
Emily C WoodsDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305, United States.ORCID 0000-0003-3140-8458
Ki Wan ParkDepartment of Otolaryngology-Head & Neck Surgery Divisions, Stanford University School of Medicine, Stanford, California 94305, United States.
Nichole J PedowitzDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305, United States.
Joanna Jaworek-KorjakowskaDepartment of Automatic Control and Robotics, AGH University of Krakow, Krakow 30-059, Poland.
Sijie WangDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305, United States.
Tulio A ValdezDepartment of Otolaryngology-Head & Neck Surgery Divisions, Stanford University School of Medicine, Stanford, California 94305, United States.
Matthias FellnerBiochemistry Department, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0003-3192-6984
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, California 94305, United States.ORCID 0000-0003-3753-4412
Stanford University · USJagiellonian University · PLUniversity of Otago · NZ

Funding

Stanford Clinician Scientist Training ProgramR25DC020174 · NIDCD · STANFORD UNIVERSITY · PI Alan Gi-Lun Cheng · 2022 to 2026
$1.8M
Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agentsR01EB026332 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.4M
NIBIB NIH HHS R01 EB026332NIDCD NIH HHS R25 DC020174
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAnimalsAnti-Bacterial AgentsBiofilmsDisease Models, AnimalHumansMiceSerineAnti-Bacterial AgentsSerine

Identifiers

PMID38411555
OpenAlexW4392182978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.